Accordingly, a recent population-based study shows that plasma copeptin (a surrogate marker of AVP) is a predictor for the occurrence of CKD [18], a chronic disease affecting ~13.4% of the population worldwide [19]. Here, AVP is linked to chronic kidney disease.